(NYSE: LCI) today announced that it has commenced marketing Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, the therapeutic equivalent to the reference listed drug, Aggrenox
Capsules, 25 mg/200 mg, of Boehringer Ingelheim Pharmaceuticals, Inc.
(NYSE: LCI), a company that develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications, announced on Tuesday that it has started marketing Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, the therapeutic equivalent to the reference listed drug, Aggrenox
Capsules, 25 mg/200 mg, from Boehringer Ingelheim Pharmaceuticals Inc.
In a research note to investors, Steadman says ANI is set for several value-creating launches this year including the remaining Concerta strengths, a generic Aggrenox
, a vancomycin oral solution and an undisclosed approved generic priority review product.
Judge Underhill of the District of Connecticut in Aggrenox
, (136) Judge
The settlement made between all 50 states and the District of Columbia solves allegations that BIPI engaged in unfair, deceptive, or misleading practices in its promotion of Micardis, Aggrenox
, Atrovent, and Combivent by allegedly representing that the prescription drugs had sponsorship, approval, characteristics, ingredients, uses, benefits, quantities, or qualities that they did not have.
16, 2015); iMtnictal, 791 F.3d at 397; In re Aggrenox
Antitrust Litig, 94 F.
Otro caso es el del Aggrenox
, recetado para pacientes con derrames y trombosis, que la alemana Boehringer Ingelheim logro retardar hasta 2015.
Other antiplatelet drugs include clopidogrel (Plavix), ticlopidine (Ticlid), dipyridamole (Persantine) and Aggrenox
, a combination of dipyridamole and aspirin.
Dipyridamole Vasodilator that Indications: Mostly used inhibits cGMP in combination with phosphodiesterase and other drugs such as cellular uptake of aspirin (Aggrenox
) or adenosine.
The DOJ announced yesterday that Boehringer will pay $95 million to resolve the allegations that it improperly promoted its anti-stroke drug Aggrenox
, its chronic obstructive pulmonary disease drugs Atrovent and Combivent, and its hypertension drug Micardis.
Dupont notes that antiplatelet drugs reduce the relative risk of stroke recurrence and that the combination of aspirin and dipyridamole (Aggrenox
) seems to be more effective than aspirin alone.
The same is true for the temporary discontinuation of drugs such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), clopidogrel (Plavix), aspirin/ extended release dipyridamole (Aggrenox
), and vitamin E.